Broadcast Date: Wednesday, May 24, 2023
from 12:00 pm to 1:30 pm (ET)


In 2022, new legislation, evolving regulations and policies, supply chain disruptions, and public health crises dominated the FDA regulatory landscape.  In 2023, FDA is expected to continue to implement its new legislative authorities, advance its regulation of cutting-edge issues, address significant supply chain concerns, and deal with the fallout from the COVID-19 public health emergency.

In this LIVE Webcast, a panel of key thought leaders and practitioners assembled by The Knowledge Group will provide the audience with an in-depth analysis of the latest trends and issues shaping the food and drug industry today. Speakers will discuss key FDA initiatives and offer best practices to help life sciences industry stakeholders successfully navigate this evolving legal climate, mitigate compliance risks, and maximize potential opportunities.

Key topics include:

  • Key Legislative Developments
  • FDA Policy Priorities
  • DOJ and FDA Enforcement Outlook
  •  Compliance Best Practices


Course Level:



Advance Preparation:

Print and review course materials


Method of Presentation:

Live Webcast



General knowledge of food and drug regulations


Course Code:



NY Category of CLE Credit:

Areas of Professional Practice


Total Credits:

1.5 CLE


Joshua Oyster, Partner
Experienced Life Sciences Regulatory Attorney

Ropes & Gray LLP

Josh Oyster is a partner in Ropes & Gray’s Life Sciences Regulatory & Compliance practice.  He steers clients through a wide range of FDA regulatory issues to help them bring innovative products to market while also ensuring regulatory compliance. Josh is regularly called upon for help with a range of enforcement, regulatory compliance and transactional matters. Josh routinely helps companies navigate FDA inspections, Warning Letters, product recalls, and other compliance and enforcement matters. He is frequently tapped to analyze clients’ toughest questions related to complex or ambiguous regulatory requirements, drawing on his extensive experience with key policy and enforcement priorities, including medical product promotion, digital health, drug compounding, data integrity, CBD, and developments arising from the COVID-19 pandemic. In addition, Josh assists clients in assessing regulatory risks associated with potential acquisitions and investments in FDA-regulated entities.


Joshua Oyster, Partner

Ropes & Gray LLP

Date & Time:

Wednesday, May 24, 2023

12:00 pm to 1:30 pm (ET)

A recording will be available to view 24-48 hours after the live date.


Coming Soon.

Please check back again later.

Who Should Attend:

  • FDA Attorneys
  • FDA Specialists
  • FDA Inspectors
  • Operations Executives
  • Compliance Executives and Officers
  • Regulatory Executives and Officers
  • General Counsel from Food/Drug/Beverage Industries


Joshua OysterPartner
Experienced Life Sciences Regulatory Attorney
Ropes & Gray LLP



View Details


View Details


View Details

Join Over 150,000 Professionals Empowering Their Careers

Learn anywhere from over 1900+ live and recorded CLE, CPE & Technology Webcasts.